Literature DB >> 20164301

Reversal of prolonged dopamine inhibition of dopaminergic neurons of the ventral tegmental area.

Sudarat Nimitvilai1, Mark S Brodie.   

Abstract

Drug abuse-induced plasticity of putative dopaminergic (pDAergic) ventral tegmental area (VTA) neurons may play an important role in changes in the mesocorticolimbic system that lead to the development of addiction. In the present study, extracellular recordings were used to examine time-dependent effects of dopamine (DA) on pDAergic VTA neurons in rat brain slices. Administration of DA (2.5-10 microM) for 40 min resulted in inhibition followed by partial or full reversal of that inhibition. The reduced sensitivity to DA inhibition lasted 30 to 90 min after washout of the long-term dopamine administration. The inhibition reversal was not observed with 40-min administration of the D2 agonist quinpirole (25-200 nM), so this phenomenon was not the result of desensitization induced solely by stimulation of D2 DA receptors. Inhibition reversal could be observed with the coapplication of quinpirole and the D1/D5 agonist SKF38393 [(+/-)-1-phenyl-2,3,4,5-tetrahydro-(1H)-3-benzazepine-7,8-diol hydrobromide], suggesting a D1/D5 mechanism for the reversal. Furthermore, D1/D5 antagonists, given in the presence of prolonged DA exposure, prevented the inhibition reversal. Application of 3 microM quinpirole caused desensitization to low quinpirole concentrations that was blocked by a D1/D5 antagonist. These data suggest that coactivation of D1/D5 receptors and D2 receptors in the VTA results in desensitization of autoinhibitory D2 receptors. Prolonged increases in pDAergic tone in the VTA that may occur in vivo with drugs of abuse could reduce the regulation of firing by D2 dopamine receptor activation, producing long-term alteration in information processing related to reward and reinforcement.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20164301      PMCID: PMC2872954          DOI: 10.1124/jpet.109.163931

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  44 in total

1.  Dopamine D5 receptors of rat and human brain.

Authors:  Z U Khan; A Gutiérrez; R Martín; A Peñafiel; A Rivera; A de la Calle
Journal:  Neuroscience       Date:  2000       Impact factor: 3.590

2.  Dopamine D(5) receptor immunolocalization in rat and monkey brain.

Authors:  B J Ciliax; N Nash; C Heilman; R Sunahara; A Hartney; M Tiberi; D B Rye; M G Caron; H B Niznik; A I Levey
Journal:  Synapse       Date:  2000-08       Impact factor: 2.562

3.  Ethanol directly excites dopaminergic ventral tegmental area reward neurons.

Authors:  M S Brodie; C Pesold; S B Appel
Journal:  Alcohol Clin Exp Res       Date:  1999-11       Impact factor: 3.455

4.  Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity.

Authors:  B S Bunney; J R Walters; R H Roth; G K Aghajanian
Journal:  J Pharmacol Exp Ther       Date:  1973-06       Impact factor: 4.030

5.  Sulpiride blocks the action of dopamine in the rat substantia nigra.

Authors:  R D Pinnock; G N Woodruff; M J Turnbull
Journal:  Eur J Pharmacol       Date:  1979-07-01       Impact factor: 4.432

6.  Preferential stimulation of dopamine release in the nucleus accumbens of freely moving rats by ethanol.

Authors:  A Imperato; G Di Chiara
Journal:  J Pharmacol Exp Ther       Date:  1986-10       Impact factor: 4.030

Review 7.  Dopamine and drug addiction: the nucleus accumbens shell connection.

Authors:  Gaetano Di Chiara; Valentina Bassareo; Sandro Fenu; Maria Antonietta De Luca; Liliana Spina; Cristina Cadoni; Elio Acquas; Ezio Carboni; Valentina Valentini; Daniele Lecca
Journal:  Neuropharmacology       Date:  2004       Impact factor: 5.250

Review 8.  The dopamine hypothesis of schizophrenia: version III--the final common pathway.

Authors:  Oliver D Howes; Shitij Kapur
Journal:  Schizophr Bull       Date:  2009-03-26       Impact factor: 9.306

9.  The control of firing pattern in nigral dopamine neurons: single spike firing.

Authors:  A A Grace; B S Bunney
Journal:  J Neurosci       Date:  1984-11       Impact factor: 6.167

10.  Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia.

Authors:  Helena T Mueller; Vahram Haroutunian; Kenneth L Davis; James H Meador-Woodruff
Journal:  Brain Res Mol Brain Res       Date:  2004-02-05
View more
  26 in total

1.  Dopamine D₂ and acetylcholine α7 nicotinic receptors have subcellular distributions favoring mediation of convergent signaling in the mouse ventral tegmental area.

Authors:  M Garzón; A M Duffy; J Chan; M-K Lynch; K Mackie; V M Pickel
Journal:  Neuroscience       Date:  2013-08-15       Impact factor: 3.590

2.  Anaplastic lymphoma kinase regulates binge-like drinking and dopamine receptor sensitivity in the ventral tegmental area.

Authors:  John W Dutton; Hu Chen; Chang You; Mark S Brodie; Amy W Lasek
Journal:  Addict Biol       Date:  2016-01-11       Impact factor: 4.280

3.  Reversal of dopamine D2 agonist-induced inhibition of ventral tegmental area neurons by Gq-linked neurotransmitters is dependent on protein kinase C, G protein-coupled receptor kinase, and dynamin.

Authors:  Sudarat Nimitvilai; Maureen A McElvain; Mark S Brodie
Journal:  J Pharmacol Exp Ther       Date:  2012-09-27       Impact factor: 4.030

4.  Anaplastic Lymphoma Kinase Regulates Internalization of the Dopamine D2 Receptor.

Authors:  Donghong He; Amy W Lasek
Journal:  Mol Pharmacol       Date:  2019-11-16       Impact factor: 4.436

5.  Reversal of dopamine inhibition of dopaminergic neurons of the ventral tegmental area is mediated by protein kinase C.

Authors:  Sudarat Nimitvilai; Devinder S Arora; Mark S Brodie
Journal:  Neuropsychopharmacology       Date:  2011-10-05       Impact factor: 7.853

6.  Dopamine D2 receptor desensitization by dopamine or corticotropin releasing factor in ventral tegmental area neurons is associated with increased glutamate release.

Authors:  Sudarat Nimitvilai; Melissa Herman; Chang You; Devinder S Arora; Maureen A McElvain; Marisa Roberto; Mark S Brodie
Journal:  Neuropharmacology       Date:  2014-03-19       Impact factor: 5.250

7.  Morphine administration modulates expression of Argonaute 2 and dopamine-related transcription factors involved in midbrain dopaminergic neurons function.

Authors:  D García-Pérez; F Sáez-Belmonte; M L Laorden; C Núñez; M V Milanés
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

8.  Reversal of inhibition of putative dopaminergic neurons of the ventral tegmental area: interaction of GABA(B) and D2 receptors.

Authors:  S Nimitvilai; D S Arora; M A McElvain; M S Brodie
Journal:  Neuroscience       Date:  2012-09-15       Impact factor: 3.590

9.  Amphetamine self-administration attenuates dopamine D2 autoreceptor function.

Authors:  Erin S Calipari; Haiguo Sun; Khalil Eldeeb; Deborah J Luessen; Xin Feng; Allyn C Howlett; Sara R Jones; Rong Chen
Journal:  Neuropsychopharmacology       Date:  2014-02-11       Impact factor: 7.853

10.  Midbrain Dopamine Controls Anxiety-like Behavior by Engaging Unique Interpeduncular Nucleus Microcircuitry.

Authors:  Steven R DeGroot; Rubing Zhao-Shea; Leeyup Chung; Paul M Klenowski; Fangmiao Sun; Susanna Molas; Paul D Gardner; Yulong Li; Andrew R Tapper
Journal:  Biol Psychiatry       Date:  2020-06-30       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.